Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DN-101, Mitoxantrone, and Prednisone in Androgen-Independent Prostate Cancer
NCT00182741Phase 2Completed
- Sponsor
- OHSU Knight Cancer Institute
- Start
- Sep 2004
- Primary completion
- Aug 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of calcitriol in prostate cancer (PCa), sponsored by OHSU Knight Cancer Institute. Started Sep 2004; status: completed.
02
Drugs
calcitriol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00182741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182741.